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1466for the global estimate, and increased for the
segmental estimates for all SSFP estimates (5% vs.
9%, respectively). The variability between masked
and original SSFP estimates was largest for ExMyo
and Contour estimates.
Through-plane motion is likely to introduce errors
in strain. Because tags are created orthogonal to the
image plane, the tagging strain estimate is more robust
to through-plane motion. A 3-dimensional analysis
may give better agreement between untagged and
tagged estimates. Limitations include differences in
slice thickness (6 mm for SSFP and 8 mm for tagging),
which may give rise to small differences in strain.
Masking the myocardium also introduces different
endocardial and epicardial image edge features, which
may inﬂuence the feature tracking results. However,
Figure 1B shows that the Myo mask did not signiﬁ-
cantly change segmental estimates.
Our results support the conclusions that global
strain is primarily determined by changes in the
circumference, and that features outside the myocar-
dium greatly inﬂuence segmental strain estimates.
Because the anterior insertion point of the RV free wall
into the interventricular septum curves around the
left ventricle, through-plane motion gives rise to
apparent deformation. Also, relative motions of pap-
illaries and trabeculae give rise to strain artifacts. The
pericardium also creates a potential discontinuity
between myocardial and extracardiac motion.Brett R. Cowan, BE, MB, ChB
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2012;67:1590–9.[68Ga]Pentixafor-PET/CT for Imaging
of Chemokine Receptor 4 Expression After
Myocardial InfarctionDue to the inability of myocytes to regenerate, acute
and sustained ischemia usually results in irreversible
myocardial damage and subsequent remodeling pro-
cesses. Chemokine receptor 4 (CXCR4)/stromal cell-
derived factor (SDF)-1a play a pivotal role in the
recruitment and homing of stem and progenitor cells
to the infarct zone (1). Prolonged myocardial SDF-1a
expression after infarction has been demonstrated to
result in beneﬁcial outcomes (2) Additionally, CXCR4
is normally expressed on various immune cells and
therefore is involved in the orchestration of post-
infarct inﬂammation and its resolution (3).
Recently, a radiolabeled CXCR4 ligand ([68Ga]
Pentixafor) for positron emission tomography (PET)
imaging has been developed (4). This is the ﬁrst
report of noninvasive detection of CXCR4 expression
in the human myocardium after acute myocardial
infarction.
Seven patients (4 men and 3 women, mean age
62  14 years) with (sub)acute myocardial infarction
underwent imaging with cardiac magnetic resonance
(CMR) (n ¼ 6) and Pentixafor-PET (all, 126 to 161 MBq/
patient) within 5 to 10 days after symptom onset
(mean 8  2 days; delay between PET and CMR 1.0 
0.5 days). All patients gave written informed consent
before imaging. Static PET scans were acquired 60
min post-injection using an integrated PET/computed
tomography (CT) scanner (Siemens Biograph mCT 64,
Siemens, Knoxville, Tennessee). CMR was performed
on a 1.5-T scanner (Achieva 1.5T, Philips Healthcare,
Best, the Netherlands) including steady-state free
precession cine, T2-weighted turbo spin echo, and
multishot inversion recovery turbo ﬁeld echo
sequences.
Images were ﬁrst inspected visually. For quantiﬁ-
cation of increased tracer uptake, a visual score using
the terms mild, moderate, and intense was employed.
Affected areas were documented using the 17-
segment American Heart Association heart model.
For semiquantitative analysis, a 15-mm circular
region was placed over the infarcted areas to derive
maximum standardized uptake value (SUVmax) and
FIGURE 1 Increased 68Ga-Pentixafor Uptake in Acute Myocardial Infarction Affecting the Left Anterior Descending Artery
Axial slices of both (A) contrast-enhanced multishot inversion recovery turbo ﬁeld echo cardiac magnetic resonance (CMR) and (B) CXCR4-
positron emission tomography (PET), as well as (C) fused PET/computed tomography. Images reveal increased 68Ga-Pentixafor uptake in the
apex that consistently matches myocardial damage in CMR (arrows).
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1467mean standardized uptake value (SUVmean). For
reference, a second region of interest (diameter of
15 mm) was placed in a remote region of the left
ventricular wall. Signal-to-background ratios were
calculated.
Acute myocardial infarction was diagnosed by
elevated cardiac enzymes, ST-segment elevations,
and coronary angiography. The left anterior
descending coronary artery was affected in 5 patients,
and the right coronary artery, in 2 subjects. All
patients were on antihypertensive medications
(including beta-blockers, hydrochlorothiazide, and
calcium channel blockers) and underwent mechanical
revascularization within 20 h after symptom onset.
On CMR, infarcts comprised 7% to 30% of the
myocardium; left ventricular ejection fractions
ranged from 37% to 67%.
Pentixafor-PET was visually positive in 3 of 7
patients (CMR available in 2 of 3). Overall, retention
of the radiotracer was rated mild (5 segments) or
moderate (5 segments). No segment was rated
intense. CXCR4-PET and CMR were concordantly
positive in 9 of 10 segments with no PET-positive,
CMR-negative segments (Figure 1). The remaining 4
patients did not show increased tracer accumulation.
Of note, there was no substantial difference
between the “positive” (days 5, 8, and 8) and “nega-
tive” (days 6, 8, 9, and 10) patients regarding the
timing of imaging after onset of clinical symptoms.
SUVmean in infarcted areas ranged from 2.0 to 3.3,
and SUVmax, from 2.1 to 3.7, respectively. The
SUVmean and SUVmax ratios of lesion to remote
myocardium were 2.1  0.2 and 2.0  0.4, respec-
tively. Median troponin T and maximum creatine
kinase levels were 2,106 pg/ml (range 1,285 to13,058 pg/ml) and 1,065 U/l (range 631 to 3,570 U/l) in
PET-positive patients compared with 670 pg/ml (range
36 to 1,936) and 538.5 U/l (range 386 to 1,933 U/l) in
PET-negative subjects.
This is the ﬁrst report to our knowledge of in vivo
imaging of CXCR4 in the human heart after myocar-
dial infarction. Enhanced chemokine expression
could be observed in 3 of 7 patients, with tracer
uptake 2-fold higher in the infarcted myocardium as
compared with remote myocardium. Of note, PET-
positive patients presented with higher troponin
and creatine kinase levels than negative subjects.
One might speculate that increased myocardial dam-
age with hypoxia leads to CXCR4 up-regulation
in order to initiate healing processes of the damaged
myocardium (5). Interestingly, 4 patients proved
Pentixafor negative in the presence of acute
myocardial damage on CMR.
However, given the very limited number of obser-
vations, as well as the lack of histological proof, no
ﬁnal conclusions can be drawn yet, especially as the
true source of the signal detected by Pentixafor-PET
has not been identiﬁed yet. In general, both he-
matopoietic stem cells and neutrophils are potential
cellular origins. Neutrophils are known to outnumber
hematopoietic progenitors in acutely inﬂamed
myocardium and may therefore be the likely source of
the imaging signal. However, the timing of PET was
somewhat late (mean 8  2 days after onset of
symptoms) because neutrophils are thought to
dominate very early. Additionally, up-regulation of
CXCR4 by cardiac myocytes has been demonstrated
to occur after 36 to 48 h after acute infarction (5).
Future studies including serial imaging starting at
earlier time points are warranted.
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1468Although the data would beneﬁt from corrobora-
tion, further pre-clinical support is prevented by high
speciﬁcity of the tracer for the human CXCR4,
limiting all investigation to the human setting. New
ligands enabling experiments in another species are
not yet available.
In summary, this ﬁrst proof-of-concept investiga-
tion demonstrates the general possibility to examine
and quantify alterations in CXCR4 receptor density
after myocardial infarction by means of Pentixafor-
PET/CT.Constantin Lapa, MD*
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infarction. FASEB J 2007;21:3197–207.Evidence of a Direct Effect of Myocardial
Steatosis on LV Hypertrophy and Diastolic
Dysfunction in Adult and Adolescent ObesityPrevious studies have shown that myocardial steatosis
occurs with age, diabetes, and themetabolic syndromeand that myocardial triglyceride content (MTGC) is
related to concentric left ventricular hypertrophy
(LVH) (1) and diastolic dysfunction (2), suggesting
a direct negative effect on the heart. Despite this,
whether a relationship between MTGC, concentric
LVH, and diastolic function exists in obesity per se is
unclear and in childhood obesity remains unknown.
1H-magnetic resonance spectroscopy (1H-MRS) is a
technique that can measure MTGC noninvasively (3).
We used 1H-MRS and cardiovascular magnetic reso-
nance imaging to explore the relationship between
increasing body fat and MTGC; the relationship be-
tween MTGC, LVH, and diastolic dysfunction; and
whether any changes were present in an adolescent
population.
A total of 128 adult subjects (71 female; body mass
index [BMI], 18.5 to 53.0 kg/m2) and 22 male adoles-
cents (10 to 15 years of age, BMI percentile 8 to 100)
underwent 1H-MRS and left ventricular (LV) studies,
as previously described (4,5). Total body fat content
(DXA, GE Lunar system, GE Healthcare, New York,
New York) and abdominal visceral fat mass (fourth/
ﬁfth lumbar water-suppressed turbo spin echo) were
also assessed. Age, BMI, systolic blood pressure (SBP),
and diastolic blood pressure were similar in men and
women. All subjects were normotensive (adults, 121 
11/74  8 mm Hg; children, 113  13/67  10 mm Hg),
normoglycemic (adults, 5.0  0.5 mmol/l; children,
4.8  0.6 mmol/l), and normocholesterolemic (adults,
5.1  0.8 mmol/l; children, 3.9  0.5 mmol/l). The
mean homeostatic model assessment of insulin resis-
tance (HOMA-IR) was 2.7  1.3 (adult population). All
subjects had normal LV ejection fraction (>58%).
In adults, although MTGC was positively correlated
with all measures of obesity (BMI, r ¼ 0.59; visceral
fat, r ¼ 0.46; total fat, r ¼ 0.60; females; BMI, r ¼ 0.53)
(Figure 1), only total fat mass (þ0.013%/kg fat,
p < 0.001) was an independent predictor of MTGC. No
sex difference in the regression coefﬁcient for the
associations of obesity with MTGC was seen. In ado-
lescents, MTGC was also positively correlated with
BMI percentile (r ¼ 0.45, p ¼ 0.035).
Increasing BMI was associated with LV cavity
dilation in both males (r ¼ 0.32, p ¼ 0.014) and females
(LV end-diastolic volume, r ¼ 0.39, p < 0.001).
In contrast, with increasing BMI, concentric LV
remodeling was only seen in males (LV mass, volume
ratio; r ¼ 0.44, p ¼ 0.01) and was positively correlated
with MTGC (r ¼ 0.39, p ¼ 0.003), a relationship that
remained after adjustment for SBP and HOMA-IR
(r ¼ 0.40, p < 0.005). In adolescent male subjects,
increasing BMI percentile was not related to cavity
dilation (r ¼ 0.32, p ¼ 0.14), but again was positively
correlated with indexed LV mass (g/m2.7, r ¼ 0.54,
